Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

. Financial System and Expanding Economic Opportunity', held via Cisco Webex, with testimony from Commodity Futures Trading Commission Commissioner Rostin Behnam; Fermat Capital Management Senior Underwriter and Director of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggi

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

S. Financial System and Expanding Economic Opportunity, held via Cisco Webex, with testimony from Commodity Futures Trading Commission Commissioner Rostin Behnam; Fermat Capital Management Senior Underwriter and Director of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggi

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

. Financial System and Expanding Economic Opportunity', held via Cisco Webex, with testimony from Commodity Futures Trading Commission Commissioner Rostin Behnam; Fermat Capital Management Senior Underwriter and Director EFTA01658536 of New Markets Joanna Syroka; Environmental Defense Fund Director of Worki